SG Americas Securities
CGON icon

SG Americas Securities’s CG Oncology CGON Stock Holding History

SG Americas Securities’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.67M Buy
24,632
+3,683
+18% +$209K ﹤0.01% 1482
2025
Q4 		$870K Buy
20,949
+10,077
+93% +$417K ﹤0.01% 2126
2025
Q3 		$438K Buy
10,872
+1,601
+17% +$46.5K ﹤0.01% 2209
2025
Q2 		$241K Buy
9,271
+3,792
+69% +$91.4K ﹤0.01% 2148
2025
Q1 		$134K Buy
+5,479
New +$154K ﹤0.01% 2836
2024
Q4 		– Sell
-17,595
Closed -$664K – 3194
2024
Q3 		$664K Buy
+17,595
New +$617K ﹤0.01% 1439

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SG Americas Securities's CGON Position: Q1 2026 in Review

SG Americas Securities increased its CG Oncology (CGON) stake by 18% in Q1 2026, buying an estimated $209K and bringing the position to 24,632 shares worth $1.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1482.

SG Americas Securities first reported a position in CGON in Q3 2024 and has held it in 6 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • SG Americas Securities held 24,632 shares of CG Oncology worth $1.67M as of Q1 2026.
  • SG Americas Securities bought 3,683 CG Oncology shares in Q1 2026, an estimated $209K.
  • CG Oncology made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #1482 holding.
  • SG Americas Securities first reported a position in CG Oncology in Q3 2024 and has held it in 6 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.